American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
American Journal of Medical Case Reports. 2020, 8(1), 1-7
DOI: 10.12691/ajmcr-8-1-1
Open AccessCase Study

Acute Heart Failure in Scleroderma Renal Crisis: A Case Study for Review of Cardiac Disease in Systemic Sclerosis

Abhimanyu Amarnani1, Perry Wengrofsky1, Cindy L. Tsui1, Pramod Theetha Kariyanna1, Naureen Kabani1, Louis Salciccioli1 and Isabel M. McFarlane1,

1Department of Internal Medicine, State University of New York, Downstate Medical Center, Brooklyn, N.Y., U.S.A-11203

Pub. Date: November 05, 2019

Cite this paper:
Abhimanyu Amarnani, Perry Wengrofsky, Cindy L. Tsui, Pramod Theetha Kariyanna, Naureen Kabani, Louis Salciccioli and Isabel M. McFarlane. Acute Heart Failure in Scleroderma Renal Crisis: A Case Study for Review of Cardiac Disease in Systemic Sclerosis. American Journal of Medical Case Reports. 2020; 8(1):1-7. doi: 10.12691/ajmcr-8-1-1

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Denton CP, Khanna D. Systemic sclerosis. The Lancet. 2017; 390(10103): 1685-99.
[2]  Poudel DR, Jayakumar D, Danve A, Sehra ST, Derk CT. Determinants of mortality in systemic sclerosis: a focused review. Rheumatology international. 2018; 38(10): 1847-58.
[3]  Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of systemic sclerosis. Frontiers in immunology. 2015; 6: 272.
[4]  Launay D, Sobanski V, Hachulla E, Humbert M. Pulmonary hypertension in systemic sclerosis: different phenotypes. European Respiratory Review. 2017; 26(145): 170056.
[5]  Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013; 144(4): 1346-56.
[6]  Champion HC. The heart in scleroderma. Rheumatic Disease Clinics of North America. 2008; 34(1): 181-90.
[7]  Bournia V-K, Tountas C, Protogerou AD, Panopoulos S, Mavrogeni S, Sfikakis PP. Update on assessment and management of primary cardiac involvement in systemic sclerosis. Journal of Scleroderma and Related Disorders. 2018; 3(1): 53-65.
[8]  Venalis P, Kumánovics G, Schulze‐Koops H, Distler A, Dees C, Zerr P, et al. Cardiomyopathy in murine models of systemic sclerosis. Arthritis & Rheumatology. 2015; 67(2): 508-16.
[9]  Cucuruzac R, Muntean I, Benedek I, Mester A, Rat N, Mitre A, et al. Right Ventricle Remodeling and Function in Scleroderma Patients. BioMed research international. 2018; 2018.
[10]  Vemulapalli S, Cohen L, Hsu V. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort. Scandinavian journal of rheumatology. 2017; 46(4): 281-7.
[11]  Roque MCdF, Sampaio-Barros PD, Arruda AL, Barros-Gomes S, Becker D, Andrade JLd, et al. Evaluation of Left Ventricular Diastolic Function by Echocardiography with Tissue Doppler in Systemic Sclerosis. Arquivos brasileiros de cardiologia. 2017; 109(5): 410-5.
[12]  Mathai SC, Bueso M, Hummers LK, Boyce D, Lechtzin N, Le Pavec J, et al. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. European Respiratory Journal. 2010; 35(1): 95-104.
[13]  Forfia PR, Mathai SC, Fisher MR, Housten-Harris T, Hemnes AR, Champion HC, et al. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. American journal of respiratory and critical care medicine. 2008; 177(12): 1364-9.
[14]  Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, et al. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. American journal of respiratory and critical care medicine. 2010; 182(2): 252-60.
[15]  DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, et al. Predictors and outcomes of scleroderma renal crisis: the high‐dose versus low‐dose d‐penicillamine in early diffuse systemic sclerosis trial. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2002; 46(11): 2983-9.
[16]  Steen VD. Scleroderma renal crisis. Rheumatic diseases clinics of North America. 2003; 29(2): 315-33.
[17]  Walker JG, Ahern M, Smith M, Coleman M, Pile K, Rischmueller M, et al. Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Internal medicine journal. 2003; 33(5‐6): 216-20.
[18]  Teixeira L, Mouthon L, Mahr A, Bérezné A, Agard C, Mehrenberger M, et al. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Annals of the rheumatic diseases. 2008; 67(1): 110-6.
[19]  Desai CS, Lee DC, Shah SJ. Systemic sclerosis and the heart: current diagnosis and management. Current opinion in rheumatology. 2011; 23(6): 545.
[20]  Tennøe AH, Murbraech K, Andreassen JC, Fretheim H, Garen T, Gude E, et al. Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis. Journal of the American College of Cardiology. 2018; 72(15): 1804-13.
[21]  Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography: endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. Journal of the American Society of Echocardiography. 2010; 23(7): 685-713.
[22]  Meune C, Allanore Y, Devaux J-Y, Dessault O, Duboc D, Weber S, et al. High prevalence of right ventricular systolic dysfunction in early systemic sclerosis. The Journal of rheumatology. 2004; 31(10): 1941-5.
[23]  Follansbee W, Miller T, Curtiss E, Orie J, Bernstein R, Kiernan J, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). The Journal of Rheumatology. 1990; 17(5): 656-62.
[24]  Hachulla A-L, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Annals of the rheumatic diseases. 2009; 68(12): 1878-84.
[25]  Paroli M, De Vincentis G, Scopinaro F, Accapezzato D, Morelli S. Cardiac abnormalities in a patient with localized scleroderma. Rheumatology. 1996; 35(7): 703-4.
[26]  Paradiso M, Di Franco M, Musca A, Basili S, Riccieri V, Paoletti V, et al. Ventricular late potentials in systemic sclerosis: relationship with skin involvement. The Journal of rheumatology. 2002; 29(7): 1388-92.
[27]  Biełous‐Wilk A, Poręba M, Staniszewska‐Marszałek E, Poręba R, Podgórski M, Kałka D, et al. Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease. Annals of Noninvasive Electrocardiology. 2009; 14(3): 251-7.
[28]  Burbelo PD, Gordon SM, Waldman M, Edison JD, Little DJ, Stitt RS, et al. Autoantibodies are present before the clinical diagnosis of systemic sclerosis. PloS one. 2019; 14(3): e0214202.
[29]  Allanore Y, Meune C, Vonk M, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Annals of the rheumatic diseases. 2010; 69(01): 218-21.
[30]  Lambova S. Cardiac manifestations in systemic sclerosis. World journal of cardiology. 2014; 6(9): 993.
[31]  Trang G, Steele R, Baron M, Hudson M. Corticosteroids and the risk of scleroderma renal crisis: a systematic review. Rheumatology international. 2012; 32(3): 645-53.
[32]  Csiki, Z., Garai, I., Shemirani, A. H., Papp, G., Zsori, K. S., Andras, C., et al. (2011). The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud’s syndrome. Microvasc. Res. 82, 84–87.
[33]  Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis & Rheumatism. 2013; 65(11): 2737-47.
[34]  Butler EA, Baron M, Fogo AB, Frech T, Ghossein C, Hachulla E, et al. Generation of a core set of items to develop classification criteria for scleroderma renal crisis using consensus methodology. Arthritis & Rheumatology. 2019; 71(6): 964-71.